| Note: This medical device record is a PMA supplement. A supplement may have changed the device description/function or indication from that approved in the original PMA. Be sure to look at the original PMA record for more information. |
| |
| Device | UNI-DIRECTIONAL CELSIUS FLTR CATHETERS (D-1355-XX S) |
|---|
| Generic Name | catheter, percutaneous, cardiac ablation, for treatment of atrial flutter |
|---|
| Applicant | BIOSENSE WEBSTER, INC.
31 Technology Drive
Suite 200
Irvine, CA 92618 |
|---|
| PMA Number | P010068 |
|---|
| Supplement Number | S031 |
|---|
| Date Received | 11/07/2012 |
|---|
| Decision Date | 06/06/2013 |
|---|
| Product Code |
OAD |
| Advisory Committee |
Cardiovascular |
|---|
| Supplement Type | Normal 180 Day Track |
|---|
| Supplement Reason | Change Design/Components/Specifications/Material |
|---|
| Expedited Review Granted? | No |
|---|
| Combination Product | No |
|---|
Approval Order Statement
APPROVAL FOR MODIFIED CATHETER DESIGNS TO THE 7FR CELSIUS AND 7FR EZ STEER DS CATHETERS TO CREATE THE 7.5FR 8 MM CELSIUS FLTR CATHETERS. THE CHANGES BEING APPROVED ARE THE INCREASED DISTAL PROFILE, LARGER CURVE PROFILE, INCREASED RANGE OF DEFLECTION, AND INCREASED DEFLECTABLE TIP DIAMETER. THE DEVICES, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAMES BI-DIRECTIONAL CELSIUS FLTR CATHETERS (D-1359-XX-S) AND UNI-DIRECTIONAL CELSIUS FLTR CATHETERS (D-1355-XX-S) AND ARE INDICATED FOR CATHETER-BASED CARDIAC ELECTROPHYSIOLOGICAL MAPPING (STIMULATION AND RECORDING), AND WHEN USED WITH THE STOCKERT 70 (WITH SOFTWARE VERSION 001/033 OR HIGHER) FOR THE TREATMENT OF TYPE I ATRIAL FLUTTER IN PATIENTS AGE 18 YEARS OF AGE OR OLDER. |
|
|
